查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1956790

高通量DNA合成市場分析及預測（至2035年）：依類型、產品、服務、技術、組件、應用、形式、最終用戶及製程分類

High Throughput DNA Synthesis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Form, End User, Process
出版日期: | 出版商: Global Insight Services | 英文 379 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

高通量DNA合成市場預計將從2024年的3.276億美元成長到2034年的9.302億美元，複合年成長率約為11.4%。高通量DNA合成市場涵蓋了能夠快速、經濟高效地生產大規模DNA序列的技術。透過提供可擴展且精確的合成，該市場為合成生物學、藥物發現和基因研究提供了支持。在自動化和生物資訊學進步的推動下，該市場正在滿足對客製化DNA構建體日益成長的需求，從而促進醫療保健、農業和工業生物技術領域的創新。

受合成生物學和基因工程領域進步的推動，高通量DNA合成市場正經歷強勁成長。寡核苷酸合成領域因其在治療和診斷方面的應用而呈現最高成長率。基因合成是第二大成長領域，其成長動力來自對個人化醫療日益成長的需求以及基因組學研究的進步。自動化技術正在變革市場，提高DNA合成過程的效率並降低錯誤率。客製化DNA合成服務日益受到重視，以滿足研究機構和生技公司的特定需求。製藥和生物技術產業是市場擴張的主要促進者，這主要得益於DNA合成在藥物開發和基因研究中的應用。創新的高通量合成平台不斷湧現，為大規模計劃提供可擴展的解決方案。研發投入的加速推動了新型合成技術的開發，並擴大了市場潛力。人工智慧（AI）和機器學習的融合有望進一步變革該產業。

市場區隔
類型 寡核苷酸合成、基因合成、客製化DNA合成
產品 合成設備、試劑與耗材
服務 基因編輯、克隆與定序
科技 固相合成、晶片合成、酵素合成
成分 酵素、核苷酸、緩衝溶液
目的 合成生物學、基因工程、分子診斷、藥物發現
形式 液態凍乾產品
最終用戶 生技公司、製藥公司、學術研究機構
流程 自動合成，手動合成

高通量DNA合成市場正經歷劇烈的變革，大型生技公司佔據了顯著的市場佔有率。激烈的定價競爭和創新產品推出的湧現是當前市場格局的顯著特徵。新參與企業和老牌公司都在迅速推出先進的合成技術，以提高合成速度和準確性。這一發展趨勢是由製藥和農業領域對合成生物學應用日益成長的需求所驅動的。市場正朝著經濟高效且擴充性的解決方案發展，這對於滿足不斷成長的高通量需求至關重要。在競爭激烈的市場中，主要企業正以最尖端科技為標竿來衡量自身產品，並透過創新實現差異化。法規結構，尤其是在北美和歐洲，透過規定合規性和品質標準，對塑造市場動態起著至關重要的作用。這些法規影響打入市場策略和營運實踐。競爭格局的特點是策略聯盟和併購，旨在擴展技術能力和市場覆蓋範圍。不斷變化的監管環境既給市場參與企業帶來了挑戰，也帶來了機遇，這要求他們具備策略靈活性和合規應對力。

主要趨勢和促進因素：

由於幾個關鍵趨勢和促進因素，高通量DNA合成市場正經歷強勁成長。其中一個關鍵趨勢是合成生物學的快速發展，這推動了對高通量DNA合成技術的需求。這些進步使得更複雜、更有效率的基因工程應用成為可能，促進了市場擴張。另一個趨勢是高通量DNA合成在個人化醫療領域的應用日益廣泛。這一趨勢的驅動力在於對客製化治療方法和診斷的需求不斷成長，而這些需求需要精準快速的DNA合成能力。因此，醫療機構正在加速採用這些技術以改善患者的治療效果。此外，生物製藥研發的興起也是市場的主要驅動力。生物製藥公司正在利用高通量DNA合成來加速藥物發現過程並獲得競爭優勢。這一點在新型生物製藥和基因療法的開發中尤其明顯。此外，DNA合成成本的下降使得這些技術更容易被更廣泛的產業所採用。成本的降低正在刺激各個領域的創新，例如農業領域，人們正在開發基因改造生物以應對糧食安全挑戰。最後，主要參與者之間的策略聯盟和夥伴關係正在推動市場成長。這些合作加速了技術進步，擴大了我們高通量DNA合成解決方案的應用範圍，從而增強了我們的市場滲透率並創造了新的成長機會。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 寡核苷酸合成
    • 基因合成
    • 客製化DNA合成
  • 市場規模及預測：依產品分類
    • 合成器
    • 試劑
    • 消耗品
  • 市場規模及預測：依服務分類
    • 基因編輯
    • 複製
    • 定序
  • 市場規模及預測：依技術分類
    • 固相合成
    • 基於晶片的合成
    • 酵素合成
  • 市場規模及預測：依組件分類
    • 酵素
    • 核苷酸
    • 緩衝
  • 市場規模及預測：依應用領域分類
    • 合成生物學
    • 基因工程
    • 分子診斷
    • 藥物發現
  • 市場規模及預測：依類型
    • 液體
    • 冷凍乾燥
  • 市場規模及預測：依最終用戶分類
    • 生技公司
    • 製藥公司
    • 學術研究機構
  • 市場規模及預測：依製程分類
    • 自動化合成
    • 手工排版

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Twist Bioscience
  • Gen9
  • Genscript Biotech
  • Integrated DNA Technologies
  • DNA Script
  • Evonetix
  • Telesis Bio
  • Camena Bioscience
  • Nuclera
  • Ansa Biotechnologies
  • Molecular Assemblies
  • Ori Ciro Genomics
  • Gene Art
  • ATUM
  • Synbio Technologies
  • Arbor Biosciences
  • Enzymatics
  • Custom Array
  • Bio Basic
  • Bio Cat

第9章：關於我們

簡介目錄
Product Code: GIS10977

High Throughput DNA Synthesis Market is anticipated to expand from $327.6 million in 2024 to $930.2 million by 2034, growing at a CAGR of approximately 11.4%. The High Throughput DNA Synthesis Market encompasses technologies enabling rapid, cost-effective production of large DNA sequences. It supports synthetic biology, drug discovery, and genetic research by offering scalable and precise synthesis. Driven by advancements in automation and bioinformatics, this market addresses the increasing demand for custom DNA constructs, facilitating innovations in healthcare, agriculture, and industrial biotechnology.

The High Throughput DNA Synthesis Market is experiencing robust growth, fueled by advancements in synthetic biology and genetic engineering. The oligonucleotide synthesis segment is the top performer, driven by its applications in therapeutics and diagnostics. Gene synthesis follows as the second highest performing sub-segment, benefiting from increased demand for personalized medicine and research in genomics. Automation technologies are transforming the market, enhancing efficiency and reducing error rates in DNA synthesis processes. Custom DNA synthesis services are gaining prominence, catering to the specific needs of research institutions and biotech firms. The pharmaceutical and biotechnology sectors are major contributors to market expansion, leveraging DNA synthesis for drug development and genetic research. Innovative platforms for high-throughput synthesis are emerging, offering scalable solutions for large-scale projects. Investment in R&D is accelerating, fostering the development of novel synthesis techniques and expanding the market's potential. The integration of AI and machine learning is expected to further revolutionize the industry.

Market Segmentation
TypeOligonucleotide Synthesis, Gene Synthesis, Custom DNA Synthesis
ProductSynthesizers, Reagents, Consumables
ServicesGene Editing, Cloning, Sequencing
TechnologySolid-phase Synthesis, Chip-based Synthesis, Enzymatic Synthesis
ComponentEnzymes, Nucleotides, Buffers
ApplicationSynthetic Biology, Genetic Engineering, Molecular Diagnostics, Drug Discovery
FormLiquid, Lyophilized
End UserBiotechnology Companies, Pharmaceutical Companies, Academic and Research Institutions
ProcessAutomated Synthesis, Manual Synthesis

The High Throughput DNA Synthesis Market is experiencing a dynamic shift with significant market share held by leading biotech firms. The landscape is defined by competitive pricing strategies and a surge in innovative product launches. New entrants and established players are unveiling advanced synthesis technologies, enhancing speed and accuracy. This evolution is driven by the increasing demand for synthetic biology applications in pharmaceuticals and agriculture. The market is witnessing a trend towards cost-effective, scalable solutions, which are pivotal in addressing the growing need for high-throughput capabilities. In the realm of competition, major companies are benchmarking their offerings against cutting-edge technologies, striving for differentiation through innovation. Regulatory frameworks, particularly in North America and Europe, are critical in shaping market dynamics, dictating compliance and quality standards. These regulations influence market entry strategies and operational practices. The competitive landscape is characterized by strategic alliances and mergers, aimed at expanding technological capabilities and market reach. As regulatory landscapes evolve, they present both challenges and opportunities for market participants, necessitating strategic agility and compliance prowess.

Geographical Overview:

The High Throughput DNA Synthesis Market is witnessing remarkable growth across diverse regions, each exhibiting unique characteristics. North America leads with its advanced biotechnology infrastructure and substantial investments in synthetic biology. The presence of leading biotech firms and research institutions propels the market. Europe follows, driven by strong government support for genomics research and a robust pharmaceutical industry. In Asia Pacific, the market is expanding rapidly due to increasing demand for personalized medicine and advancements in genetic engineering. Countries like China and India are emerging as significant players, with substantial investments in biotechnology. Latin America and the Middle East & Africa are nascent markets with growing potential. In Latin America, the focus is on agricultural biotechnology, while the Middle East & Africa are recognizing the importance of DNA synthesis in healthcare innovation and genetic research. These regions are poised for growth as investments in biotechnology infrastructure increase.

Global tariffs and geopolitical tensions are significantly influencing the High Throughput DNA Synthesis Market. Japan and South Korea are increasingly investing in local biotechnological advancements to mitigate reliance on imported reagents, while China accelerates its self-reliance strategy amidst export restrictions. Taiwan, with its robust tech manufacturing capabilities, remains pivotal yet vulnerable due to its geopolitical positioning. The parent market, driven by the burgeoning demand for personalized medicine and synthetic biology, is experiencing robust growth globally. By 2035, the market is expected to thrive, propelled by innovation and strategic regional collaborations. However, ongoing Middle East conflicts could disrupt global supply chains and elevate energy prices, indirectly impacting operational costs and timelines within the DNA synthesis sector.

Key Trends and Drivers:

The High Throughput DNA Synthesis Market is experiencing robust growth due to several key trends and drivers. One significant trend is the rapid advancements in synthetic biology, which are fueling demand for high throughput DNA synthesis technologies. These advancements are enabling more complex and efficient genetic engineering applications, driving market expansion. Another trend is the increasing application of high throughput DNA synthesis in personalized medicine. This trend is driven by the growing demand for tailored therapeutics and diagnostics, which require precise and rapid DNA synthesis capabilities. Consequently, healthcare providers are increasingly adopting these technologies to enhance patient outcomes. Moreover, the rise of biopharmaceutical research and development is a major market driver. Biopharmaceutical companies are leveraging high throughput DNA synthesis to accelerate drug discovery processes, thereby increasing their competitive edge. This is particularly evident in the development of novel biologics and gene therapies. Additionally, the declining cost of DNA synthesis is making these technologies more accessible to a broader range of industries. This cost reduction is spurring innovation across sectors such as agriculture, where genetically modified organisms are being developed to address food security challenges. Finally, strategic collaborations and partnerships among key players are driving market growth. These alliances are facilitating technological advancements and expanding the reach of high throughput DNA synthesis solutions, thereby enhancing market penetration and creating new opportunities for growth.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Form
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Process

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Oligonucleotide Synthesis
    • 4.1.2 Gene Synthesis
    • 4.1.3 Custom DNA Synthesis
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Synthesizers
    • 4.2.2 Reagents
    • 4.2.3 Consumables
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Gene Editing
    • 4.3.2 Cloning
    • 4.3.3 Sequencing
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Solid-phase Synthesis
    • 4.4.2 Chip-based Synthesis
    • 4.4.3 Enzymatic Synthesis
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Enzymes
    • 4.5.2 Nucleotides
    • 4.5.3 Buffers
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Synthetic Biology
    • 4.6.2 Genetic Engineering
    • 4.6.3 Molecular Diagnostics
    • 4.6.4 Drug Discovery
  • 4.7 Market Size & Forecast by Form (2020-2035)
    • 4.7.1 Liquid
    • 4.7.2 Lyophilized
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Biotechnology Companies
    • 4.8.2 Pharmaceutical Companies
    • 4.8.3 Academic and Research Institutions
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Automated Synthesis
    • 4.9.2 Manual Synthesis

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Form
      • 5.2.1.8 End User
      • 5.2.1.9 Process
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Form
      • 5.2.2.8 End User
      • 5.2.2.9 Process
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Form
      • 5.2.3.8 End User
      • 5.2.3.9 Process
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Form
      • 5.3.1.8 End User
      • 5.3.1.9 Process
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Form
      • 5.3.2.8 End User
      • 5.3.2.9 Process
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Form
      • 5.3.3.8 End User
      • 5.3.3.9 Process
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Form
      • 5.4.1.8 End User
      • 5.4.1.9 Process
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Form
      • 5.4.2.8 End User
      • 5.4.2.9 Process
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Form
      • 5.4.3.8 End User
      • 5.4.3.9 Process
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Form
      • 5.4.4.8 End User
      • 5.4.4.9 Process
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Form
      • 5.4.5.8 End User
      • 5.4.5.9 Process
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Form
      • 5.4.6.8 End User
      • 5.4.6.9 Process
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Form
      • 5.4.7.8 End User
      • 5.4.7.9 Process
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Form
      • 5.5.1.8 End User
      • 5.5.1.9 Process
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Form
      • 5.5.2.8 End User
      • 5.5.2.9 Process
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Form
      • 5.5.3.8 End User
      • 5.5.3.9 Process
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Form
      • 5.5.4.8 End User
      • 5.5.4.9 Process
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Form
      • 5.5.5.8 End User
      • 5.5.5.9 Process
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Form
      • 5.5.6.8 End User
      • 5.5.6.9 Process
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Form
      • 5.6.1.8 End User
      • 5.6.1.9 Process
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Form
      • 5.6.2.8 End User
      • 5.6.2.9 Process
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Form
      • 5.6.3.8 End User
      • 5.6.3.9 Process
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Form
      • 5.6.4.8 End User
      • 5.6.4.9 Process
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Form
      • 5.6.5.8 End User
      • 5.6.5.9 Process

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Twist Bioscience
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Gen9
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Genscript Biotech
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Integrated DNA Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 DNA Script
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Evonetix
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Telesis Bio
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Camena Bioscience
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Nuclera
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Ansa Biotechnologies
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Molecular Assemblies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Ori Ciro Genomics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Gene Art
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 ATUM
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Synbio Technologies
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Arbor Biosciences
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Enzymatics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Custom Array
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Bio Basic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Bio Cat
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us